MR编号 | NL/H/1539/002 |
---|
药品名称 | Lamictal Dispers 5 mg, kauw/dispergeerbare tabletten |
---|
活性成分 | |
---|
剂型 | Chewable/dispersible tablet |
---|
上市许可持有人 | GlaxoSmithKline BV
Van Asch van Wijckstraat 55H
3811 LP Amersfoort
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) |
---|
互认成员国 - 产品名称 | - Lithuania (LT)
Lamictal 5 mg disperguojamosios/ kramtomosios tabletės - Hungary (HU)
- Bulgaria (BG)
Lamictal - Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
Lamictal 5 mg comprimate dispersabile/masticabile - Slovakia (SK)
Lamictal 5mg - Slovenia (SI)
- Malta (MT)
- Portugal (PT)
- Estonia (EE)
- Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
Lamictal 5 mg - lösliche Tabletten - France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Lamitrin S - Latvia (LV)
Lamictal 5 mg disperģējamās/košļājamās tabletes
|
---|
许可日期 | 2008/09/25 |
---|
最近更新日期 | 2024/04/22 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|